George Bickerstaff

Insider profile

Currently holds positions in CareDx Inc and Innoviva Inc

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 21% 68% 82%
Transactions
15 27% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director CareDx Inc April 1, 2014 -
Independent Director Innoviva Inc Dec. 19, 2017 -
Independent Director Axovant Gene Therapies Ltd Feb. 12, 2018 - Feb. 19, 2020
Director Inovio Pharmaceuticals Inc March 21, 2017 - May 11, 2018
Director BIOLASE Inc June 16, 2014 - Dec. 31, 2017
Independent Director ARIAD Pharmaceuticals Inc April 1, 2016 - Feb. 16, 2017

George Bickerstaff's trades of CareDx Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
423.93
Quantity 96,762 +0.1%
Value US$4,169,119
Transaction date
Proposed sale
Price
281.79
Quantity 42,648
Value US$2,881,674
Transaction date
Sale
Price
340.39
Quantity 99,210 -46.8%
Value US$3,850,535
Transaction date
Proposed sale
Price
18.36
Quantity 20,000
Value US$367,102
Transaction date
Sale
Price
39.11
Quantity 25,000 -39.8%
Value US$977,672
Transaction date
Purchase
Price
13.46
Quantity 10,000 +8.7%
Value US$134,619
Transaction date
Purchase
Price
12.97
Quantity 10,000 +9.6%
Value US$129,670
Transaction date
Sale
Price
75.97
Quantity 799 -1.3%
Value US$60,700
Transaction date
Sale
Price
75.28
Quantity 9,201 -13.0%
Value US$692,673
Transaction date
Sale
Price
63.75
Quantity 600 -0.8%
Value US$38,248
Transaction date
Sale
Price
63.03
Quantity 9,400 -11.6%
Value US$592,499
Transaction date
Sale
Price
72.84
Quantity 2,076 -2.5%
Value US$151,219
Transaction date
Sale
Price
72.04
Quantity 3,224 -3.8%
Value US$232,248
Transaction date
Sale
Price
71.10
Quantity 4,700 -5.2%
Value US$334,177
Transaction date
Sale
Price
27.65
Quantity 10,000 -10.5%
Value US$276,458
Transaction date
Purchase
Price
15.90
Quantity 15,000 +38.7%
Value US$238,500
Transaction date
Purchase
Price
14.90
Quantity 10,000 +34.8%
Value US$148,958
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-06 2026-08-05 S Sale
96,762 +0.1%
423.93
US$4,169,119
96,762 +0.1% 423.93 US$4,169,119
2026-08-05 2026-08-05 PrS Proposed sale
42,648
281.79
US$2,881,674
42,648 281.79 US$2,881,674
2025-03-12 2025-03-10 S Sale
99,210 -46.8%
340.39
US$3,850,535
99,210 -46.8% 340.39 US$3,850,535
2025-03-10 2025-03-10 PrS Proposed sale
20,000
18.36
US$367,102
20,000 18.36 US$367,102
2022-03-01 2022-02-28 S Sale
25,000 -39.8%
39.11
US$977,672
25,000 -39.8% 39.11 US$977,672
2021-05-25 2021-05-24 B Purchase
10,000 +8.7%
13.46
US$134,619
10,000 +8.7% 13.46 US$134,619
2021-05-25 2021-05-21 B Purchase
10,000 +9.6%
12.97
US$129,670
10,000 +9.6% 12.97 US$129,670
2021-05-21 2021-05-21 S Sale
799 -1.3%
75.97
US$60,700
799 -1.3% 75.97 US$60,700
2021-05-21 2021-05-21 S Sale
9,201 -13.0%
75.28
US$692,673
9,201 -13.0% 75.28 US$692,673
2021-05-13 2021-05-12 S Sale
600 -0.8%
63.75
US$38,248
600 -0.8% 63.75 US$38,248
2021-05-13 2021-05-12 S Sale
9,400 -11.6%
63.03
US$592,499
9,400 -11.6% 63.03 US$592,499
2020-12-14 2020-12-14 S Sale
2,076 -2.5%
72.84
US$151,219
2,076 -2.5% 72.84 US$151,219
2020-12-14 2020-12-14 S Sale
3,224 -3.8%
72.04
US$232,248
3,224 -3.8% 72.04 US$232,248
2020-12-14 2020-12-14 S Sale
4,700 -5.2%
71.10
US$334,177
4,700 -5.2% 71.10 US$334,177
2020-05-13 2020-05-13 S Sale
10,000 -10.5%
27.65
US$276,458
10,000 -10.5% 27.65 US$276,458
2019-02-28 2019-02-27 B Purchase
15,000 +38.7%
15.90
US$238,500
15,000 +38.7% 15.90 US$238,500
2019-02-22 2019-02-21 B Purchase
10,000 +34.8%
14.90
US$148,958
10,000 +34.8% 14.90 US$148,958